WARREN, N.J., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today announced an update on institutional ownership of the Company’s outstanding common stock, as reported by institutional investment managers on Form 13F filed with the Securities and Exchange Commission (SEC). As reported on June 30, 2025, second quarter institutional ownership of Tevogen common stock increased 24% compared to the reported amount on March 31, 2025; this is following a 60% i ...

公司表现与估值 - Palantir股价在过去几年从16美元飙升至185美元涨幅约1000%与特斯拉2020年从24美元涨至340美元涨幅1100%的轨迹相似[4][5] - 两家公司收入均未实现10倍增长但股价涨幅远超基本面支撑引发市场对回调的预期[5] - 特斯拉和Palantir的估值指标与传统金融模型脱节机构投资者难以用贴现现金流(DCF)等传统方法评估[6][7] 股东结构特征 - 特斯拉机构持股比例仅49%远低于同业科技巨头Alphabet(78%)和Meta(78%)[10] - Palantir机构持股比例约53%显著低于市值相近的Costco(69%)和埃克森美孚(67%)[11] - 低机构持股反映两家公司主要由散户驱动散户更关注长期技术愿景而非短期财务指标[8][9] 市场行为差异 - 散户倾向于长期持有并押注技术颠覆潜力而机构依赖历史数据预测未来导致投资逻辑分化[8] - 低机构持股使特斯拉和Palantir股价表现与传统估值脱钩呈现"非理性"波动特征[12] - 特斯拉股价历史波动性极高Palantir可能面临类似波动阶段[12]